[1]
H. Liu, “From Mechanisms to Therapeutics: Tackling Resistance in EGFR, KRAS, and ALK in NSCLC”, HSET, vol. 129, pp. 194–201, Mar. 2025, doi: 10.54097/0trsfx05.